4 reports of this reaction
2.7% of all ALUMINUM CHLOROHYDRATE reports
#6 most reported adverse reaction
CERVIX HAEMORRHAGE UTERINE is the #6 most commonly reported adverse reaction for ALUMINUM CHLOROHYDRATE, manufactured by The Procter & Gamble Manufacturing Company. There are 4 FDA adverse event reports linking ALUMINUM CHLOROHYDRATE to CERVIX HAEMORRHAGE UTERINE. This represents approximately 2.7% of all 148 adverse event reports for this drug.
Patients taking ALUMINUM CHLOROHYDRATE who experience cervix haemorrhage uterine should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CERVIX HAEMORRHAGE UTERINE is a less commonly reported adverse event for ALUMINUM CHLOROHYDRATE, but still significant enough to appear in the safety profile.
In addition to cervix haemorrhage uterine, the following adverse reactions have been reported for ALUMINUM CHLOROHYDRATE:
CERVIX HAEMORRHAGE UTERINE has been reported as an adverse event in 4 FDA reports for ALUMINUM CHLOROHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CERVIX HAEMORRHAGE UTERINE accounts for approximately 2.7% of all adverse event reports for ALUMINUM CHLOROHYDRATE, making it a notable side effect.
If you experience cervix haemorrhage uterine while taking ALUMINUM CHLOROHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.